Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells

Emily M. Esquea(Drexel University), Alexej Dick(Max Delbrück Center)
Frontiers in Pharmacology
May 16, 2024
Cited by 19


Related Papers